Status:
COMPLETED
Determination of Reference Values for Diluted Russell's Viper Venom Time (dRVVT) Specific to Pregnant Women (GRAPL)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Normal Pregnancy
Eligibility:
FEMALE
18-50 years
Brief Summary
Pregnancy is associated with significant changes in several aspects of haemostasis, especially an imbalance between procoagulant and anticoagulant factors. These changes contribute to creating a state...
Detailed Description
Please remove all personal pronouns. For example, please change "we" to "the investigators" and "you" to "participants." The "Control + Find" function (Ctrl+F) can be used to locate personal pronouns ...
Eligibility Criteria
Inclusion
- Control group :
- patients with normal pregnancies at the HCL.
- Affiliation to a social security regime
- Case group :
- Patients followed at the HCL who had an increased dRVVT ratio during pregnancy, investigated as part of the development of VDP during pregnancy.
- Affiliation to a social security regime
Exclusion
- History of thromboembolic disease
- History of autoimmune disease
- History of VDP
Key Trial Info
Start Date :
March 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 28 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06133621
Start Date
March 28 2024
End Date
September 28 2025
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Céline BAZIN
Lyon, France